5-aminoisoquinolinone has been researched along with Colonic Neoplasms in 4 studies
5-aminoisoquinolinone: structure in first source
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, Y | 1 |
| Wang, YL | 3 |
| Yang, L | 1 |
| Xu, JX | 1 |
| Xiong, W | 1 |
| Xiao, M | 1 |
| Li, M | 2 |
| Cai, L | 2 |
| Threadgill, MD | 1 |
| Wang, Y | 1 |
| Wu, WQ | 1 |
| Fauzee, NJ | 1 |
| Hao, LX | 1 |
| Li, YY | 1 |
4 other studies available for 5-aminoisoquinolinone and Colonic Neoplasms
| Article | Year |
|---|---|
Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
Topics: 3-Iodobenzylguanidine; ADP Ribose Transferases; Cell Line, Tumor; Colonic Neoplasms; Gene Expression | 2013 |
Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells.
Topics: Animals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Separation; Colon | 2009 |
5-Aminoisoquinolinone reduces the expression of vascular endothelial growth factor-C via the nuclear factor-κB signaling pathway in CT26 cells.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Isoquinolines; Lymphangiogenesis; Mice; NF-kappa B; Po | 2012 |
[Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29].
Topics: Cell Adhesion; Cells, Cultured; Colonic Neoplasms; Female; HT29 Cells; Humans; Intercellular Adhesio | 2007 |